Altium Capital Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-18,292
Closed -$307K 138
2021
Q2
$307K Buy
+18,292
New +$307K 0.07% 127